Phototherapy and exchange transfusion for neonatal hyperbilirubinaemia: National academic hospitals' consensus guidelines for South African hospitals and primary care facilities

South African Medical Journal

Volumn 96, Issue 9, 2006, Pages 819-824

  Horn, A R ^a   Kirstern, G F ^b   Kroon, S M ^a   Henning, P A ^b   Moller G ^a   Pieper, C ^a   Adhikari, M ^c   Cooper, P ^d   Hoek, B ^e   Delport, S ^f   Nazo, M ^g   Mawela, B ^h  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF THE FREE STATE   (South Africa)

^f UNIVERSITY OF PRETORIA   (South Africa)

^g WALTER SISULU UNIVERSITY   (South Africa)

^h SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ADVISEMENT; ARTICLE; CAUSE OF DEATH; CONSENSUS DEVELOPMENT; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXCHANGE BLOOD TRANSFUSION; HOSPITAL CARE; HUMAN; KERNICTERUS; LOW BIRTH WEIGHT; NEONATOLOGY; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PRACTICE GUIDELINE; PREMATURITY; PRIMARY MEDICAL CARE; SOUTH AFRICA; TIME; VERY LOW BIRTH WEIGHT;

BILIRUBIN; EXCHANGE TRANSFUSION, WHOLE BLOOD; HOSPITALS, UNIVERSITY; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PHOTOTHERAPY; PRIMARY HEALTH CARE; SOUTH AFRICA;

EID: 33749044210     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Skae MS, Moise J, Clarke P. Is current management of neonatal jaundice evidence based? Arch Dis Child Fetal Neonatal Ed 2005; 90: F540.
2. Ahdab-Barmada M, Moossy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. J Neuropathol Exp Neurol 1984; 43: 45-56.
3. Hsia DY, Allen FH jr, Gellis SS, Diamond LK. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med 1952; 247: 668-671.
4. Oski FA, Naiman JL. Hematologic problems in the newborn. Major Problems in Clinical Pediatrics 1972; 4: 200.
5. Cockington RA. A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. J Pediatr 1979; 95: 281-285.
6. Karabus CD. Phototherapy of neonatal jaundice at a general children's hospital. In: Brown AKSJ, ed. Phototherapy for Neonatal Hyperbilirubinaemia: Long-term Implications. Washington, DC: US Government Printing Office, 1974: 95.
7. Harrison VC. The Newborn Baby, 4th ed. Cape Town: Juta, 2002.
8. Ip S, Chung M, Kulig J. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e130-153.
9. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001; 107: 1075-1080.
10. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics 1993; 92: 651-657.
11. Johnson L, Bhutani VK. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol 1998; 25: 558-574, viii.
12. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
13. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics. Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics 1994; 94: 558-565.
14. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour- specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6-14.
15. Bhutani VL, Johnson LH. Jaundice technologies: prediction of hyperbilirubinemia in term and near-term newborns. J Perinatol 2001; 21 (suppl 1): S76-82; discussion S83-87.
16. National Institute of Child Health and Human Development randomized, controlled trials of phototherapy for neonatal hyperbilirubinemia. Pediatrics 1985; 75: 385-441.
17. Watchko JF, Claassen D. Kernicterus in premature infants: current prevalence and relationship to NICHD Phototherapy Study exchange criteria. Pediatrics 1994; 93: 996-999.
18. Cashore WJ. Bilirubin and jaundice in the micropremie. Clin Perinatol 2000; 27: 171-179, vii.
19. Watchko JF, Maisels MJ. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed 2003; 88: F455-458.
20. Maisels MJ. Jaundice. In: Avery GB, Fletcher MA, MacDonald M, eds. Neonatology: Pathophysiology and Management of the Newborn. Philadelphia: JB Lippincott, 1999: 765-819.
21. Ives NK. Neonatal jaundice. In: Rennie JM, Roberton NRC, eds. Textbook of Neonatology. New York Churchill Livingstone, 1999: 715-732.
22. Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 1994; 93: 488-494.
23. Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: F459-463.
24. Tan KL. The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinemia. Pediatr Res 1982; 16: 670-674.
25. Lazar L, Litwin A, Merlob P. Phototherapy for neonatal nonhemolytic hyperbilirubinemia. Analysis of rebound and indications for discontinuing therapy. Clin Pediatr (Phila) 1993; 32: 264-267.
26. Yetman RJ, Parks DK, Huseby V, Mistry K, Garcia J. Rebound bilirubin levels in infants receiving phototherapy. J Pediatr 1998; 133: 705-707.
27. Maisels MJ, Kring E. Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolesc Med 2002; 156: 669-672.